Breadcrumb

  1. Our vision
  2. EMEA News

EMEA News

Displaying 1 - 10 of 33
Thu 8 October, 2020
Santen is delighted to announce the launch of the Re-SOLVE Antibiotic Resist
Thu 8 October, 2020
Santen EMEA is proud to support World Sight Day (WSD) 2020, an annual
Thu 17 September, 2020
Santen is proud to release its annual Santen Report 2020 to mark the end of fiscal year 2019 and introduce its ne
Tue 30 June, 2020
As COVID-19 continues to impact hundreds of thousands of people across the world, many healthcare systems are struggling to cope with the strain imposed by the virus. 
Thu 28 May, 2020
Santen EMEA and NTC, an international pharmaceutical company headquartered in Italy with expertise in research and development, are delighted to announce the completion and positive outcome of
Thu 28 May, 2020
As a healthcare company that is well represented across the globe. Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.
Wed 13 May, 2020
Santen and jCyte, a clinical stage biotech company focused on degenerative retinal diseases, have announced the conclusion of an exc
Tue 5 May, 2020
As the COVID-19 pandemic continues to impact families, communities and businesses, healthcare systems are re-configuring to address the challenge.
Thu 23 April, 2020
On Wednesday 22 April 2020, over 700 EMEA colleagues and 40 guests from our headquarters in Japan, joined Santen’s first ever Virtual Conference.
Mon 13 April, 2020
As a healthcare company that is well represented across the globe, Santen’s mission is to contribute to the well-being of patients, their loved ones and consequently to society.